539938 — Medico Intercontinental Income Statement
0.000.00%
- IN₹447.50m
- IN₹462.39m
- IN₹713.55m
- 87
- 80
- 12
- 66
Annual income statement for Medico Intercontinental, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 820 | 697 | 743 | 762 | 714 |
Cost of Revenue | |||||
Gross Profit | 126 | 121 | 134 | 139 | 165 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 777 | 649 | 692 | 707 | 654 |
Operating Profit | 43 | 48.1 | 51 | 55.6 | 59.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 32 | 35.3 | 42.3 | 49.4 | 54.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.6 | 25.8 | 31 | 36.1 | 39.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 23.6 | 25.8 | 31 | 36.1 | 39.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.6 | 25.8 | 31 | 36.1 | 39.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.25 | 7.93 | 9.54 | 5.61 | 3.95 |
Dividends per Share |